Christian Viskov

USPTO Granted Patents = 16 (Patent Applications = 10)

EPO Patents = 15 (Patent Applications = 16)

Average Co-Inventor Count = 2.2

ph-index = 3

Forward Citations = 52(Granted Patents)

Location History:

Combs la Ville, FR (2011)
Ris Orangis, FR (2003 - 2014)
Paris, FR (2013 - 2016)

Company Filing History:

Aventis Pharma Limited

patents

Years Active: 2003-2016

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9346894 - Polysaccharides comprising two antithrombin III-binding sites, preparation thereof and use thereof as antithrombotic medicaments (2016-05-24),

2. 8652785 - Method of screening a modulator of endothelial NO synthase comprising the use of heme binding protein 1 (2014-02-18),

3. 8546354 - Acylated decasaccharides and their use as antithrombotic agents (2013-10-01),

4. 8518909 - Sulfated heptasaccharide and its use as an antithrombotic agent (2013-08-27),

5. 8501711 - Acylated 1,6-anhydro decasaccharide and its use as an antithrombotic agent (2013-08-06),

6. 8071570 - Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them (2011-12-06),

7. 8003623 - Mixtures of sulfated oligosaccharides (2011-08-23),

8. 7956046 - Oligosaccharide mixtures derived from heparin, preparation thereof and pharmaceutical compositions containing them (2011-06-07),

9. 7812007 - Compositions of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them (2010-10-12),

10. 7687274 - Method for determining specific groups constituting heparins or low molecular weight heparins (2010-03-30),

11. 7678766 - Process for the preparation of cyclosporin derivatives (2010-03-16),

12. 7575930 - Method for analyzing oligosaccharides from blood plasma (2009-08-18),

13. 7226905 - Process for the preparation of cyclosporin derivatives (2007-06-05),

14. 6969705 - Compositions of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them (2005-11-29),

15. 6617316 - Oligosaccharides, their preparation and pharmaceutical compositions containing them (2003-09-09),

Title: The Innovations of Christian Viskov

Introduction

Christian Viskov is a notable inventor based in Ris Orangis, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of antithrombotic medicaments. With a total of 16 patents to his name, Viskov's work has had a profound impact on cardiovascular health.

Latest Patents

One of Viskov's latest patents involves polysaccharides that comprise two antithrombin III-binding sites. This invention relates to sulphated polysaccharides with a molecular weight of less than 8000 Daltons. These polysaccharides have a general structure similar to that of heparin and are designed for use as antithrombotic medicaments. Another significant patent is a method of screening a modulator of endothelial NO synthase (eNOS). This method is crucial for diagnosing cardiovascular diseases and involves the use of heme binding protein 1 (HEBP-1) for identifying potential medicaments.

Career Highlights

Throughout his career, Christian Viskov has worked with prominent companies in the pharmaceutical industry, including Aventis Pharma and Sanofi. His experience in these organizations has allowed him to develop innovative solutions that address critical health issues.

Collaborations

Viskov has collaborated with several professionals in his field, including Pierre Mourier and Elisabeth Perrin. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Christian Viskov's contributions to medicinal chemistry and his innovative patents highlight his importance as an inventor. His work continues to influence the development of treatments for cardiovascular diseases, showcasing the vital role of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.